Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Lynn StockwellCEO and Exe. Chair of Board | Drugs Made In America Acquisition IIDMII | Open-market buy | 25/09/26 | 25/10/01 | 700,000 sh | In footnote | No stated value | +4.9% |
Lynn StockwellCEO and Exe. Chair of Board | Drugs Made In America Acquisition IIDMII | Open-market sale | 25/09/26 | 25/10/01 | 7,966,667 sh | In footnote | No stated value | −54.3% |
Drugs Made In America Acquisition II10% Owner | Drugs Made In America Acquisition IIDMII | Open-market buy | 25/09/26 | 25/10/01 | 700,000 sh | In footnote | No stated value | +4.9% |
Drugs Made In America Acquisition II10% Owner | Drugs Made In America Acquisition IIDMII | Open-market sale | 25/09/26 | 25/10/01 | 7,966,667 sh | In footnote | No stated value | −54.3% |